The Approach to Obesity Management in the UK: A Review, Opportunities and Next Steps
With the advent of several first generation GLP-1 agonist [...]
Commercial Clinical Trials in the UK: the Lord O’Shaughnessy review
On 26th May 2023, the government published a report [...]
CF shortlisted for three awards at HSJ Partnership Awards 2023
We are delighted to have been nominated for three [...]
CF wins Project of the Year at the MCA Awards 2022
We were delighted to walk away with three project [...]
Potential impact of Teledermatology on NHS backlogs – The case for adoption
This report was commissioned and funded by AbbVie. Summary [...]
Value-based agreements: the future of life sciences deals in the UK?
Innovation and disruption in life sciences (LS) and healthcare present [...]
Creating Collaborative Opportunities for Life Sciences in NHS Integrated Care Systems
1. How can Lifesciences Partner Effectively with ICSs? Many [...]
What will it mean to improve outcomes for lung cancer patients?
Every four minutes someone in the UK dies from cancer, [...]
Building analytical tools to support COVID-19 capacity planning in London
CF supported NHS London in developing a suite of [...]
Data strategy for digital devices
CF supported a global life science company to generate [...]
